JW Pharmaceutical Corp (001067.KS) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · South Korea · ISIN KR7001062009

Price
49,700.00 KRW
Market cap
1.12 tn KRW
P/E (2025)
18.22
P/S (2025)
1.45
Dividend yield
1.31 %
Net margin
7.93 %
Return on equity (ROE)
16.65 %
Return on assets (ROA)
10.16 %

JW Pharmaceutical Corp financials

Fiscal year20242025
Revenue719.38 bn KRW775.30 bn KRW
Gross profit323.50 bn KRW359.31 bn KRW
Operating income82.73 bn KRW94.46 bn KRW
EBIT92.45 bn KRW93.26 bn KRW
Net income65.04 bn KRW61.51 bn KRW
Diluted EPS – continuing operations2,804.17 KRW2,727.83 KRW

Full history since 2014, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About JW Pharmaceutical Corp

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is based in Gwacheon-si, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.